A decision on booster shots for the approximately 13.8 million Americans who received Johnson & Johnson’s single-shot coronavirus vaccine is likely to take weeks, according to people familiar with the issue. Federal health officials are waiting on results from a government-backed clinical trial and from studies by Johnson & Johnson to determine whether those who… read on > read on >












-300x211.jpeg)





